LUMASIRAN

LUMASIRAN was reported 386 times

LUMASIRAN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 GLYCOLIC ACID INCREASED 1 1.0000
1 HYPEROXALAEMIA 9 0.7500
2 RENAL AND LIVER TRANSPLANT 12 0.6000
3 URINE OXALATE DECREASED 3 0.5000
4 PRIMARY HYPEROXALURIA 1 0.3333
5 COMPLEMENT FACTOR C4 1 0.3333
6 URINE OXALATE INCREASED 17 0.2329
7 OXALOSIS 12 0.1579
8 HYDROCALYX 1 0.1111
9 URETEROSCOPY 1 0.1000
10 VITAMIN SUPPLEMENTATION 1 0.0714
11 CARDIOVASCULAR EVALUATION 1 0.0370
12 PSYCHOTHERAPY 1 0.0333
13 HYPOCITRATURIA 2 0.0308
14 UNADJUSTED DOSE ADMINISTERED 2 0.0294
15 RENAL ARTERY STENT PLACEMENT 4 0.0247
16 NOONAN SYNDROME 1 0.0175
17 RENAL TRANSPLANT 55 0.0152
18 MULTISYSTEM INFLAMMATORY SYNDROME IN CHILDREN 1 0.0139
19 ORGAN TRANSPLANT 1 0.0102
20 DIALYSIS HYPOTENSION 1 0.0101
21 SHUNT THROMBOSIS 1 0.0101
22 TRANSITIONAL CELL CARCINOMA METASTATIC 1 0.0085
23 NEPHROCALCINOSIS 10 0.0084
24 OBSTRUCTIVE NEPHROPATHY 1 0.0081
25 RENAL REPLACEMENT THERAPY 1 0.0078
26 PERFORATION BILE DUCT 1 0.0077
27 RENAL STONE REMOVAL 4 0.0072
28 CALCULUS URETHRAL 1 0.0065
29 HYPEROXALURIA 1 0.0058
30 URETERAL STENT INSERTION 2 0.0057
31 CUTANEOUS CALCIFICATION 1 0.0055
32 MACULAR SCAR 1 0.0052
33 WEIGHT DECREASE NEONATAL 1 0.0052
34 STENT REMOVAL 1 0.0051
35 RETINAL DEPOSITS 1 0.0049
36 RENAL CORTICAL NECROSIS 1 0.0043
37 NEPHRECTOMY 6 0.0040
38 LIMB TRAUMATIC AMPUTATION 1 0.0037
39 RENAL ARTERY STENOSIS 5 0.0036
40 MILK ALLERGY 2 0.0036
41 LIVER TRANSPLANT 13 0.0036
42 CRYSTAL NEPHROPATHY 2 0.0034
43 LITHIASIS 1 0.0033
44 INCREASED DOSE ADMINISTERED 1 0.0032
45 INGUINAL HERNIA REPAIR 1 0.0030
46 GASTROENTERITIS CLOSTRIDIAL 1 0.0028
47 CHRONIC RESPIRATORY DISEASE 1 0.0028
48 DIALYSIS RELATED COMPLICATION 1 0.0028
49 CATHETER REMOVAL 1 0.0028
50 PRODUCT ADMINISTERED BY WRONG PERSON 1 0.0026
51 TRANSIENT TACHYPNOEA OF THE NEWBORN 1 0.0025
52 URETERAL DISORDER 1 0.0024
53 UTERINE MASS 1 0.0024
54 PULMONARY CALCIFICATION 1 0.0024
55 BLOOD HOMOCYSTEINE INCREASED 1 0.0023
56 INJECTION SITE RECALL REACTION 1 0.0020
57 ACCIDENT AT HOME 1 0.0019
58 URETEROLITHIASIS 2 0.0019
59 INFECTED FISTULA 1 0.0019
60 PERIORBITAL CELLULITIS 1 0.0019
61 LEFT ATRIAL ENLARGEMENT 1 0.0019
62 URINARY TRACT INFECTION FUNGAL 1 0.0017
63 DISTRACTIBILITY 2 0.0017
64 DOSE CALCULATION ERROR 1 0.0017
65 TRANSPLANT 4 0.0017
66 VITRECTOMY 1 0.0017
67 LYMPHATIC DISORDER 1 0.0017
68 THIRST DECREASED 1 0.0016
69 LYMPHOCELE 1 0.0015
70 INJECTION SITE EXFOLIATION 1 0.0015
71 HEAD AND NECK CANCER 1 0.0015
72 NUTRITIONAL CONDITION ABNORMAL 1 0.0014
73 SERRATIA INFECTION 1 0.0013
74 ARTERIAL RUPTURE 1 0.0013
75 GASTROSTOMY 2 0.0013
76 SUPERINFECTION BACTERIAL 1 0.0013
77 GOUTY ARTHRITIS 1 0.0013
78 ABDOMINAL SYMPTOM 1 0.0012
79 PARATHYROID DISORDER 1 0.0012
80 HYPERVOLAEMIA 6 0.0012
81 PERITONEAL DIALYSIS 1 0.0012
82 NEONATAL HYPOXIA 1 0.0012
83 VENA CAVA THROMBOSIS 2 0.0012
84 CATHETER MANAGEMENT 1 0.0011
85 RENAL TRANSPLANT FAILURE 1 0.0010
86 CELL DEATH 2 0.0010
87 MUCOSAL DISORDER 1 0.0010
88 DEVICE RELATED SEPSIS 2 0.0010
89 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 2 0.0010
90 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 1 0.0009
91 AMAUROSIS FUGAX 1 0.0009
92 RENAL COLIC 2 0.0009
93 COMPLICATIONS OF TRANSPLANTED KIDNEY 2 0.0009
94 FEBRILE INFECTION 1 0.0008
95 HYPERTENSIVE EMERGENCY 1 0.0008
96 DIALYSIS 12 0.0008
97 PNEUMONIA INFLUENZAL 1 0.0008
98 NEPHROLITHIASIS 38 0.0008
99 RENAL TUBULAR INJURY 1 0.0008
100 LARGE INTESTINE INFECTION 1 0.0008
101 HEPATOSPLENOMEGALY 2 0.0008
102 RETINAL DEGENERATION 1 0.0008
103 CALCULUS BLADDER 1 0.0007
104 GLOMERULAR FILTRATION RATE ABNORMAL 1 0.0007
105 INVESTIGATION ABNORMAL 1 0.0007
106 BLOOD PARATHYROID HORMONE INCREASED 2 0.0007
107 GROWTH RETARDATION 2 0.0007
108 VASCULAR RUPTURE 1 0.0006
109 OSTEOSCLEROSIS 1 0.0006
110 LIMB DEFORMITY 1 0.0006
111 INJECTION SITE ATROPHY 1 0.0006
112 SPINAL DEFORMITY 1 0.0006
113 POST PROCEDURAL HAEMATOMA 1 0.0006
114 HEPATORENAL SYNDROME 1 0.0006
115 HEPATIC FIBROSIS 2 0.0006
116 ANURIA 5 0.0006
117 LABORATORY TEST ABNORMAL 17 0.0006
118 APPENDICECTOMY 2 0.0006
119 CATHETER PLACEMENT 1 0.0005
120 ARTERIAL THROMBOSIS 1 0.0005
121 POST PROCEDURAL DISCOMFORT 1 0.0005
122 SLEEP DEFICIT 1 0.0005
123 INTENTIONAL DOSE OMISSION 13 0.0005
124 END STAGE RENAL DISEASE 8 0.0004
125 EYELID DISORDER 1 0.0004
126 DISCOURAGEMENT 1 0.0004
127 POLYOMAVIRUS-ASSOCIATED NEPHROPATHY 1 0.0004
128 ESCHERICHIA BACTERAEMIA 1 0.0004
129 KIDNEY TRANSPLANT REJECTION 2 0.0004
130 GASTROINTESTINAL TUBE INSERTION 1 0.0004
131 VENTRICULAR HYPERTROPHY 1 0.0004
132 AORTIC ARTERIOSCLEROSIS 1 0.0004
133 HAEMOLYSIS 3 0.0004
134 HERNIA REPAIR 1 0.0004
135 RETINAL DISORDER 1 0.0004
136 TRANSPLANT REJECTION 3 0.0004
137 RENAL TUBULAR DISORDER 1 0.0004
138 PANCREATIC CARCINOMA METASTATIC 1 0.0004
139 ENTEROCOLITIS 2 0.0003
140 FINE MOTOR SKILL DYSFUNCTION 1 0.0003
141 STRABISMUS 1 0.0003
142 URINE ANALYSIS ABNORMAL 1 0.0003
143 CENTRAL VENOUS CATHETERISATION 1 0.0003
144 INJECTION SITE VESICLES 2 0.0003
145 CRANIOCEREBRAL INJURY 1 0.0003
146 DIASTOLIC DYSFUNCTION 1 0.0003
147 INJECTION SITE HYPERSENSITIVITY 1 0.0003
148 DEAFNESS NEUROSENSORY 1 0.0003
149 LISTLESS 1 0.0003
150 MICTURITION DISORDER 1 0.0003
151 CARDIAC DYSFUNCTION 1 0.0003
152 HYDRONEPHROSIS 2 0.0003
153 CONJUNCTIVAL HAEMORRHAGE 1 0.0003
154 THERAPEUTIC PRODUCT EFFECT VARIABLE 1 0.0003
155 NAIL DISCOLOURATION 1 0.0003
156 GLOMERULAR FILTRATION RATE DECREASED 3 0.0002
157 ARTHRITIS BACTERIAL 1 0.0002
158 HYPERPYREXIA 1 0.0002
159 POOR PERIPHERAL CIRCULATION 1 0.0002
160 CARDIAC FAILURE CHRONIC 1 0.0002
161 METASTATIC NEOPLASM 1 0.0002
162 PYELONEPHRITIS 2 0.0002
163 TONGUE DISCOLOURATION 1 0.0002
164 CYTOMEGALOVIRUS VIRAEMIA 1 0.0002
165 GASTROINTESTINAL INFECTION 2 0.0002
166 HAEMOGLOBIN INCREASED 1 0.0002
167 BLOOD TEST ABNORMAL 3 0.0002
168 GASTROENTERITIS 3 0.0002
169 INCORRECT DOSAGE ADMINISTERED 1 0.0002
170 PROTEIN URINE PRESENT 1 0.0002
171 FLUID INTAKE REDUCED 1 0.0002
172 PATHOLOGICAL FRACTURE 1 0.0002
173 EYELID PTOSIS 2 0.0002
174 PRODUCT TEMPERATURE EXCURSION ISSUE 1 0.0002
175 PERIORBITAL OEDEMA 1 0.0002
176 RENAL PAIN 2 0.0002
177 ANAL ABSCESS 1 0.0002
178 HIP SURGERY 1 0.0002
179 CHOKING SENSATION 1 0.0002
180 INTRACRANIAL PRESSURE INCREASED 1 0.0002
181 EOSINOPHILIA 3 0.0002
182 SCOLIOSIS 1 0.0002
183 HOSPITALISATION 21 0.0001
184 DRUG EFFECT LESS THAN EXPECTED 2 0.0001
185 INSURANCE ISSUE 2 0.0001
186 UTERINE CANCER 1 0.0001
187 STENT PLACEMENT 1 0.0001
188 SHOCK HAEMORRHAGIC 1 0.0001
189 POLYURIA 1 0.0001
190 ATRIAL SEPTAL DEFECT 1 0.0001
191 HAEMODIALYSIS 1 0.0001
192 BLOOD MAGNESIUM DECREASED 1 0.0001
193 THERAPY INTERRUPTED 8 0.0001
194 OPTIC NEURITIS 1 0.0001
195 HIDRADENITIS 1 0.0001
196 PRODUCT DOSE OMISSION IN ERROR 3 0.0001
197 FRACTURE 2 0.0001
198 PRESCRIBED OVERDOSE 2 0.0001
199 AUTOIMMUNE DISORDER 1 0.0001
200 BONE PAIN 6 0.0001
201 OVARIAN CYST 1 0.0001
202 PREGNANCY 2 0.0001
203 SPINAL FRACTURE 2 0.0001
204 INITIAL INSOMNIA 1 0.0001
205 PERITONITIS 2 0.0001
206 WEIGHT FLUCTUATION 1 0.0001
207 SUDDEN DEATH 1 0.0001
208 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
209 METABOLIC ACIDOSIS 3 0.0001
210 LIVER FUNCTION TEST INCREASED 2 0.0001
211 LACTIC ACIDOSIS 3 0.0001
212 PHARYNGITIS STREPTOCOCCAL 1 0.0001
213 OESOPHAGITIS 1 0.0001
214 GAMMA-GLUTAMYLTRANSFERASE INCREASED 2 0.0001
215 FISTULA 1 0.0001
216 IMPAIRED DRIVING ABILITY 1 0.0001
217 PRODUCT AVAILABILITY ISSUE 2 0.0001
218 DERMATITIS CONTACT 1 0.0001
219 INTERNAL HAEMORRHAGE 1 0.0001
220 EYELID OEDEMA 1 0.0001
221 ACUTE KIDNEY INJURY 13 0.0001
222 MACULAR DEGENERATION 1 0.0001
223 MUSCLE RIGIDITY 1 0.0001
224 ILL-DEFINED DISORDER 5 0.0001
225 BLOOD ALKALINE PHOSPHATASE INCREASED 2 0.0001
226 INJECTION SITE DISCOLOURATION 1 0.0001
227 UNEVALUABLE EVENT 6 0.0001
228 BLOOD CREATININE INCREASED 5 0.0001
229 CENTRAL NERVOUS SYSTEM LESION 1 0.0001
230 RESPIRATORY DISTRESS 2 0.0001
231 CARPAL TUNNEL SYNDROME 1 0.0001
232 DEVICE OCCLUSION 1 0.0001
233 MYELODYSPLASTIC SYNDROME 1 0.0001
234 INJECTION SITE HAEMATOMA 1 0.0001
235 COMPLICATION ASSOCIATED WITH DEVICE 1 0.0001
236 SURGERY 4 0.0001
237 HAEMORRHAGE INTRACRANIAL 1 0.0001
238 INJECTION SITE RASH 2 0.0001
239 NERVOUS SYSTEM DISORDER 2 0.0001
240 BLOOD POTASSIUM INCREASED 1 0.0001
241 PERICARDITIS 1 0.0001
242 RENAL IMPAIRMENT 5 0.0001
243 SYRINGE ISSUE 1 0.0001
244 HYPERKALAEMIA 2 0.0001
245 ASPARTATE AMINOTRANSFERASE INCREASED 3 0.0001
246 DYSURIA 2 0.0001
247 SEPSIS 6 0.0001
248 BACTERIAL INFECTION 1 0.0001
249 PHOTOPHOBIA 1 0.0001
250 BLOOD URINE PRESENT 1 0.0001
251 GASTRIC ULCER 1 0.0001
252 KIDNEY INFECTION 1 0.0001
253 PRESCRIBED UNDERDOSE 1 0.0001
254 TASTE DISORDER 1 0.0000
255 URINARY TRACT INFECTION 8 0.0000
256 FAECES DISCOLOURED 1 0.0000
257 PRODUCT PRESCRIBING ISSUE 1 0.0000
258 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
259 RENAL FAILURE 6 0.0000
260 LIVER DISORDER 2 0.0000
261 TRANSAMINASES INCREASED 1 0.0000
262 PRODUCT DOSE OMISSION ISSUE 13 0.0000
263 DISEASE PROGRESSION 5 0.0000
264 INFECTION 6 0.0000
265 NEURALGIA 1 0.0000
266 INJECTION SITE URTICARIA 1 0.0000
267 CHRONIC KIDNEY DISEASE 3 0.0000
268 HAEMATEMESIS 1 0.0000
269 THERAPY CESSATION 2 0.0000
270 JOINT STIFFNESS 1 0.0000
271 LIMB INJURY 1 0.0000
272 DIVERTICULITIS 1 0.0000
273 PROCEDURAL PAIN 1 0.0000
274 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1 0.0000
275 LETHARGY 2 0.0000
276 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
277 SEIZURE 4 0.0000
278 INTENTIONAL PRODUCT USE ISSUE 3 0.0000
279 RESPIRATORY DISORDER 1 0.0000
280 DISCOMFORT 2 0.0000
281 FEMUR FRACTURE 1 0.0000
282 CYSTITIS 1 0.0000
283 STAPHYLOCOCCAL INFECTION 1 0.0000
284 HEART RATE INCREASED 3 0.0000
285 VIRAL INFECTION 1 0.0000
286 URINARY RETENTION 1 0.0000
287 TRANSIENT ISCHAEMIC ATTACK 1 0.0000
288 ILLNESS 3 0.0000
289 INJECTION SITE REACTION 2 0.0000
290 SLEEP DISORDER 2 0.0000
291 MOBILITY DECREASED 2 0.0000
292 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 5 0.0000
293 NO ADVERSE EVENT 5 0.0000
294 HYPOAESTHESIA 4 0.0000
295 DYSPNOEA EXERTIONAL 1 0.0000
296 COLITIS 1 0.0000
297 GAIT DISTURBANCE 5 0.0000
298 ABORTION SPONTANEOUS 1 0.0000
299 FOETAL EXPOSURE DURING PREGNANCY 2 0.0000
300 POLLAKIURIA 1 0.0000
301 CARDIO-RESPIRATORY ARREST 1 0.0000
302 DEVICE DISLOCATION 1 0.0000
303 SEPTIC SHOCK 1 0.0000
304 INJECTION SITE PAIN 7 0.0000
305 DEHYDRATION 3 0.0000
306 WEIGHT INCREASED 5 0.0000
307 THERAPEUTIC PRODUCT EFFECT DECREASED 1 0.0000
308 SUICIDAL IDEATION 2 0.0000
309 PNEUMONIA 7 0.0000
310 RENAL DISORDER 1 0.0000
311 ARRHYTHMIA 1 0.0000
312 PULMONARY EMBOLISM 2 0.0000
313 MULTIPLE SCLEROSIS 1 0.0000
314 HYPOGLYCAEMIA 1 0.0000
315 SYNCOPE 2 0.0000
316 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
317 PANCREATITIS 1 0.0000
318 HYPERTENSION 4 0.0000
319 DISTURBANCE IN ATTENTION 1 0.0000
320 RASH PRURITIC 1 0.0000
321 MEDICATION ERROR 1 0.0000
322 PANCYTOPENIA 1 0.0000
323 NECK PAIN 1 0.0000
324 HYPONATRAEMIA 1 0.0000
325 GENERAL PHYSICAL HEALTH DETERIORATION 2 0.0000
326 SUICIDE ATTEMPT 1 0.0000
327 INJECTION SITE ERYTHEMA 2 0.0000
328 EXPOSURE DURING PREGNANCY 1 0.0000
329 AMNESIA 1 0.0000
330 SWELLING FACE 1 0.0000
331 DEATH 13 0.0000
332 BLOOD PRESSURE DECREASED 1 0.0000
333 NEOPLASM MALIGNANT 1 0.0000
334 NEUTROPENIA 2 0.0000
335 MULTIPLE SCLEROSIS RELAPSE 1 0.0000
336 ABDOMINAL PAIN UPPER 3 0.0000
337 WEIGHT DECREASED 4 0.0000
338 INJURY 1 0.0000
339 OVERDOSE 3 0.0000
340 CONSTIPATION 3 0.0000
341 INCORRECT DOSE ADMINISTERED 3 0.0000
342 BLOOD PRESSURE INCREASED 2 0.0000
343 DECREASED APPETITE 3 0.0000
344 BACK PAIN 3 0.0000
345 DRUG INEFFECTIVE 17 0.0000
346 ABDOMINAL PAIN 3 0.0000
347 CARDIAC FAILURE 1 0.0000
348 THROMBOSIS 1 0.0000
349 GASTROOESOPHAGEAL REFLUX DISEASE 1 0.0000
350 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
351 PYREXIA 4 0.0000
352 INTENTIONAL PRODUCT MISUSE 1 0.0000
353 MUSCULOSKELETAL STIFFNESS 1 0.0000
354 COVID-19 2 0.0000
355 PAIN 7 0.0000
356 MATERNAL EXPOSURE DURING PREGNANCY 1 0.0000
357 GASTROINTESTINAL DISORDER 1 0.0000
358 ADVERSE DRUG REACTION 1 0.0000
359 DIARRHOEA 7 0.0000
360 OROPHARYNGEAL PAIN 1 0.0000
361 CHEST PAIN 2 0.0000
362 CARDIAC DISORDER 1 0.0000
363 NEUROPATHY PERIPHERAL 1 0.0000
364 CONTUSION 1 0.0000
365 FATIGUE 8 0.0000
366 DYSPEPSIA 1 0.0000
367 DIZZINESS 5 0.0000
368 OFF LABEL USE 8 0.0000
369 INFLUENZA 1 0.0000
370 PALPITATIONS 1 0.0000
371 FEELING ABNORMAL 2 0.0000
372 EMOTIONAL DISTRESS 1 0.0000
373 VISUAL IMPAIRMENT 1 0.0000
374 ASTHENIA 3 0.0000
375 LOSS OF CONSCIOUSNESS 1 0.0000
376 VISION BLURRED 1 0.0000
377 MEMORY IMPAIRMENT 1 0.0000
378 ANXIETY 2 0.0000
379 MALAISE 3 0.0000
380 PAIN IN EXTREMITY 2 0.0000
381 CONDITION AGGRAVATED 2 0.0000
382 PERIPHERAL SWELLING 1 0.0000
383 VOMITING 3 0.0000
384 PARAESTHESIA 1 0.0000
385 FALL 2 0.0000
386 MYALGIA 1 0.0000
387 MUSCLE SPASMS 1 0.0000
388 ANAEMIA 1 0.0000
389 HYPOTENSION 1 0.0000
390 SOMNOLENCE 1 0.0000
391 HEADACHE 3 0.0000
392 NAUSEA 3 0.0000
393 INSOMNIA 1 0.0000
394 COUGH 1 0.0000
395 DYSPNOEA 1 0.0000